A high cholesterol reading does not automatically signal the need for medication; treatment decisions depend on a broader assessment of an individual’s overall cardiovascular risk. Consultant cardiologist Dr. Lim Bee Chian emphasizes that while elevated low-density lipoprotein (LDL) cholesterol is a significant factor, it is only one piece of the puzzle when evaluating heart health.

Cholesterol, like diabetes and hypertension, often presents without symptoms, which means individuals may be unaware of their risk. Therefore, health professionals assess a combination of factors—such as age, sex, family history, genetics, smoking status, obesity, physical inactivity, diabetes, and high blood pressure—to determine a person’s cardiovascular risk level. This risk assessment helps guide the target LDL cholesterol levels and appropriate treatment strategies.

Dr. Lim explained that LDL targets vary depending on risk category. For individuals classified as low risk, an LDL level below 3 mmol/L is generally acceptable. Moderate-risk patients should aim for levels under 2.6 mmol/L, while those at high risk should target below 1.8 mmol/L with a reduction of at least 50% from their baseline LDL. Patients considered very high risk—such as those with existing cardiovascular diseases like heart disease or stroke—should aim for LDL cholesterol levels of 1.4 mmol/L or lower, combined with at least a 50% reduction from their starting point.

For these very high-risk patients, aggressive lowering of LDL cholesterol is key to preventing further arterial plaque buildup and reducing the chance of subsequent cardiac events. Dr. Lim cautioned that surviving an initial heart attack does not guarantee survival of later attacks, as repeated events cause permanent damage to heart muscle tissue. Thus, he stressed that prevention is preferable to treating damage after it occurs.

Lifestyle changes, particularly diet and exercise, form the cornerstone of initial management and can reduce LDL cholesterol by up to approximately 30%. Patients are typically advised to follow lifestyle modifications for at least three months before reassessing progress through blood tests and weight measurements. However, for individuals with very high LDL levels or elevated cardiovascular risk, lifestyle efforts alone may not be sufficient to reach the recommended targets.

In such cases, medication is introduced, usually starting with statins, which can lower LDL cholesterol more rapidly, often within a month. If statins alone do not achieve the desired LDL levels, additional drugs may be added, including injectable PCSK9 inhibitors that enhance the liver’s ability to clear cholesterol. “Once we agree on the target LDL, we agree on the treatment plan, we’ll carry on the treatment for life,” Dr. Lim stated, noting that therapy doses may be adjusted over time based on patient response.

Regardless of medication use, Dr. Lim underscored the ongoing importance of maintaining a healthy lifestyle to manage cholesterol and reduce overall cardiovascular risk. He emphasized that effective treatment should address the full spectrum of risk factors beyond simply lowering LDL cholesterol.